LIF and glioblastoma: Further, as a cytokine, LIF is capable of supporting signaling in multiple types of immune cells and has recently been shown to be immunosuppressive in glioblastoma, highlighting a potential role for LIF inhibition as part of an immunotherapy regimen53.